USP 800
FDA Takes Steps to Advance Goals of Compounding Program
FDA Takes Steps to Advance Goals of Compounding Program
The FDA is taking new steps to better ensure the quality of compounded drugs, while also preserving patient access to these medications.
Read More >>
USP Chapter <800>: Personal Protective Equipment
Preparing for New Rules on Hazardous Drug Management
Pharmacist-Physician Collaborations Shown to be Mutually Beneficial
FDA Clearance of New Spectrum IQ Infusion System
Key Points From the 2016 NIOSH List of Antineoplastic and Hazardous Drugs in Health Care Settings
Key Points to Consider From USP <800>
New Compounding Pharmacy Policy Priorities Plan Released
View more articles >>
Multimedia: Videos
How Will USP 800 Impact the Use of Closed System Transfer Devices in Health Care?
How Will USP 800 Impact the Use of Closed System Transfer Devices in Health Care?
A Closer Look at Closed System Transfer Devices
A Closer Look at Closed System Transfer Devices
Best Practices for USP 800: Identify Gaps in Compliance
Best Practices for USP 800: Identify Gaps in Compliance
What Are the Benefits of Using Premixed IV Products?
What Are the Benefits of Using Premixed IV Products?